Clinical trial
Using the Rakai HIV Risk Index to Measure and Communicate HIV Risk to Create Demand for Safe Male Circumcision: A Randomized Controlled Trial
NCT02775357 is registered in ClinicalTrials.gov with Rakai Health Sciences Program as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using the Rakai HIV Risk Index to Measure and Communicate HIV Risk to Create Demand for Safe Male Circumcision: A Randomized Controlled Trial
- Lead sponsor
- Rakai Health Sciences Program
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- June 30, 2016
- Enrollment
- 968 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv